Synthesis and Anti-Inflammatory Activity of Novel 2-N-Alkyl Sulfonamide Substituted Derivatives of N-Phenyl Anthranilic Acid

 

Neeti Kaushik*, Abhishek Suman and S.R. Hashim

College of Pharmacy, Institute of Foreign Trade Management, Moradabad, U.P.

*Corresponding Author E-mail: neeti6@gmail.com

 

ABSTRACT:

Anthranilic acid class of NSAIDs is the result of the application of classical medicinal chemistry bioisosteric drug design concepts since these derivatives are Nitrogen isosteres of Salicylic acid. N-substituted anthranilic acids have found application in widely varying therapeutics areas including anti-inflammatory, analgesic, antipyretics, diuretics, antifibrinolytic, antimicrobial, anticancer activity. In view of these pharmacological observations of N-substituted anthranilic acid derivatives, it was thought worthwhile to synthesize some new N-substituted anthranilic acid derivatives by incorporating (substituted) benzyl and sulphonyl moieties, at the amino group of the anthranilic acid with the hope to get better anti-inflammatory and analgesic molecules.

 

Present research work deals with the substitution of N-alkyl sulfonamide group and iodine on 2nd and 7th positions of acridone nucleus respectively, to give improved antimicrobial activity. The Ullmann reaction is used for their synthesis, which is based on the reaction of o-halobenzoic acid with arylamines in n-aryl alcohol medium in the presence of potassium carbonate and copper powder. Ullmann reaction synthesizes substituted N-phenyl anthranilic acid. All the derivatives tested showed a moderate spectrum of anti-inflammatory. Thus it is possible that substitution at position 2 of the anthranilic acid by sulfonamidophenyl and modification on the sulfonamide moiety by using various amines and substituting iodine on 5th position may yield compounds of much improved activity.

 

KEYWORDS: N-phenyl anthranilic acid, Sulfonamide, Ullmann reaction, anti-inflammatory

 


 

INTRODUCTION:

The substituted derivatives of N-phenylanthranilic acid are of practical interest as compounds with different biological activities. The Ullmann reaction is used for their preparation. This is based on the reaction of o-halobenzoic acids with arylamines in the presence of potassium carbonate and copper powder as a catalyst. To increase the yield of the N-phenylanthranilic acids, the reaction is sometimes carried out in high-boiling solvents, such as nitrobutanol and DMF. Nitrobenzene and glycerine have also been reported as solvent for this reaction.

 

It is known that the rate of the Ullmann reaction1 in the synthesis of diarylamines is considerably influenced by the nature of the solvent; substitution of the halogen bound to the aromatic ring is considerably facilitated by using polar aprotic solvents, such as DMF and DMSO; these solvents appreciably increase the nucleophilicity of arylamines.

 

Now, if the substituted N-phenyl anthranilic acid so obtained is treated with iodine monochloride (ICl), the iodine is expected to get attached to the position-5 of the anthranilic acid moiety and then 5-iodo-N-(substituted) phenyl anthranilic acids will be obtained2,J-3.

 

Thus, anthanilic acid derivatives of the following general structure were synthesized during the course of the present work3:

 

EXPERIMENTAL:

Materials and Methods:

Procedure for synthesis of substituted Sulfonamides (1,2,3)  : Acetanilide (20g, 0.148 mol) and chlorosulphonic acid (50 ml, 0.77 mol) were refluxed for 1 hour on a water bath,then poured on the crushed ice and filtered. Precipitate of p-acetamido benzene sulphonyl chloride (1) was obtained. A mixture of  Amine (-NR1R2) and water was added to the above product and heated with occasional swirling to just below the boiling point for about 15 minutes. It is then cooled in ice and added H2SO4, precipitate of p-acetamidobenzene sulphonamide (2) was filtered and washed with water. Above crude product was then hydrolysed with hydrochloric acid and water to give final substituted sulfonamides (3).

 

 

Preparation of N-(4-substituted sulfonamidophenyl) Anthranilic Acid (4, 5,  6):-

Vrrious substituted benzoic acids 1.6 g  (i.e. o-chlorobenzoic acid/ 2,4-dichlorobenzoic acid/ 2,chloro,4,nitrobenzoic acid), substituted sulfonamide (3) 1.72 g, potassium carbonate 1.38 gm and copper oxide 300 mg were mixed together and dissolved in DMF 5 ml. It was then heated under reflux for 3 hours on an oil bath on 150-1600C. After 3 hours of refluxing this reaction mixture was filtered and treated with dil. HCl poured on crushed ice. The solid (4,5,6) thus precipitated out was collected, filtered and washed with plenty of waterJ-1.

 

Preparation of Iodine substituted-N-(4-substituted sulfonamidophenyl) Anthranilic Acid (7):-

N-(4- substituted sulfonamidophenyl) Anthranilic Acid (0.5g) (4,5,6,) was taken in a beaker and 25 ml of 12.5% HCl was dissolved into it by continuous stirring on magnetic stirrer. A solution of 1.2 g iodine monochloride in 10 ml 25% HCl was added to the previous solution and stirred for one minute; a yellow precipitate appeared. The reaction mixture was diluted with 25 ml water and raised the temperature of well stirred mixture gradually and maintained at 900C for 15 minutes. Allowed to cool at room temperature, filtered and washed with water and dried. The compound was purified by dissolving it in dil. NaOH solution and precipitated with dil.HClJ-4.

 

PHARMACOLOGICAL EVALUATION:

(Anti-inflammatory Activity)

Paw Edema Method:

Among the many methods used for the screening of anti-inflammatory drugs Carrageenin induced paw edema method is one of the most commonly employed techniques.

 

 

This method is based upon the ability of such agents to inhibit the edema produced in the hind paw of the rat after injection of a phlogistic agent. Many phlogistic agents (irritants) have been used, such as brewer’s yeast, formaldehyde, dextran, egg albumin, kaolin, Aerosil, sulfated polysaccharides like carrageenin or naphthoylheparamine. The effect can be measured in several ways. Usually, the volume of the injected paw is measured before and after application of the irritant and the paw volume of the treated5,6.

 

Method:-

The anti-inflammatory activities of synthesized compounds were carried out by the Carrageenan Induced Paw edema method of Winter et al., 1962. The albino rats (200-300 gm) were divided into seven groups of six animals each. One group named as Control (Group-I), another was Standard (Group-II) and remaining groups were used for test groups, named as Test Group I, Test group II, Test group III, Test group IV and Test group V. Rats were weighed and marked for identification. A mark was made on left hind paw of each rat just beyond tibio-tarsal junction, so that every time the paw could be dipped in the column up to the fixed mark to ensure constant paw volume. The initial paw volume of each rat was noted by mercury displacement method. The Group-I, serving as control, was administered 5% acacia solution in a volume of 1 ml/100g, body weight, orally. Group-II, serving as standard, was administered Indomethacin (10 mg/kg, body weight, orally). Test group I, Test group II, Test group III. Test group IV and Test group V serving as test was administered synthesized compounds in the dose of 100 mg/kg body weight, orally7,8.

 

One hour after the oral administration of control, standard and test drug, 0.1 ml of 1% Carrageenan in normal saline was injected into the plantar aponeurosis of the left hind paw of each rat. The volume of the paw was measured by a plethysmometer in 1, 2, 3 and 4 hour after Carrageenan suspension injection.  The percentage increase in paw volume in animals treated with standard, synthesized compounds were compared with the increase paw volume of animals of control group after 1, 2, 3 and 4 hour.

 

RESULT AND DISCUSSION:

The N-(Aryl) anthranilic acids are a well established class of NSAIDS with several drugs which are marketed. The work done by the various workers on N-(substituted) anthranilic acids suggests that these possess diverse type of biological properties including anti-inflammatory, analgesic, antipyretic, diuretic, antimicrobial, anticancer etc.


 

 


TABLE NO. I:  N-(4-Substituted Sulfonamidophenyl) anthranilic acid

 

Sl.  No.

Compo und Code

R

R1

R2

Melting Point (0C)

% Yeild

1.

N1a

H

H

H

240-242

53.94

2.

N1b

5-I

H

H

200-203

82.3

3.

N1c

4-Cl

H

H

150-151

64.45

4.

N1d

4-Cl, 5-I

H

H

220-223

73.48

5.

N2a

4-Cl

C2H5

C2H5

150-153

58.32

6.

N2b

4-Cl,5-I

C2H5

C2H5

215-217

69.38

7.

N2c

5-NO2

C2H5

C2H5

240-241

74.81

 

 


TABLE NO. II : Effect of synthesized compounds on carrageenan Induced Rat Paw Edema

TREATMENT

DOSE

Mean increase in Paw          volume(ml)+SEM

Time in minutes

0.00

60.0

120.0

180.0

CONTROL

5 ml/kg

0.80+0.04

0.89+0.02

0.70+0.00

0.48+0.02

INDOMETHACIN

20mg/kg

0.43+0.05 (46.25)

0.36+0.04* (59.56)

0.25+0.04* (64.29)

0.28+0.05* (41.67)

N2

100 mg/kg

0.47+0.06 (41.75)

0.72+0.08 (19.10)

0.48+0.08* (31.43)

0.33+0.06* (31.25)

N1a

100 mg/kg

0.59+0.04 (26.35)

0.45+0.06* (49.43)

0.30+0.07 (57.14)

0.35+0.05 (27.08)

N2B

100mg/kg

0.71+0.05 (11.25)

0.59+0.08 (33.70)

0.49+0.06 (30.00)

0.29+0.02 (39.58)

N2c

100 mg/kg

0.65+0.05 (18.75)

0.48+0.02* (46.06)

0.35+0.06* (50.45)

0.31+0.04 (35.41)

All values are expressed as mean+SEM: n=7, * (P < 0.05) control vs. treated group, Figures in parenthesis indicate % of inhibition.

 

 


 


The antimicrobial, anti-inflammatory and analgesic activity promoted us to synthesize some new N-(Substituted)anthranilic acids which would include more effectiveness and specific activities9,10.

(Fig. 1)

 

Spectral Analysis :-

N1b.

IR (KBr) in cm-1 (Figure 5) :-  3500.2 (O-H stretching), 2927.6 (C-H stretching), 1696 (C=O stretching), 1549 (C=C stretching), 672 (C-I stretching),1253(N-H stretching).  1HNMR (300 MHz, CDCl3) δ in ppm (figure 6):-

δ 7.04 ( 1H, aromatic C-H), δ 8.00 (1H, secondary N-H), δ 3.20 ( 2H, CH2)

 

N1c.

IR (KBr) in cm-1 (Figure 5) :-  3507.2 (O-H stretching), 2931.6 (C-H stretching), 1711 (C=O stretching), 1609 (C=C stretching), 678.4 (C-I stretching),1203(N-H stretching).

1HNMR (300 MHz, CDCl3) δ in ppm (figure 6):-

δ 7.06 ( 1H, aromatic C-H), δ 8.20 (1H, secondary N-H), δ 3.23 ( 2H, CH2)

 

N2b.

IR (KBr) in cm-1 (Figure 5) :-  3491.2 (O-H stretching), 2967.6 (C-H stretching), 1706 (C=O stretching), 1621 (C=C stretching), 679 (C-I stretching),1297(N-H stretching).

1HNMR (300 MHz, CDCl3) δ in ppm (figure 6):-

δ 7.12 ( 1H, aromatic C-H), δ 8.06(1H, secondary N-H), δ 3.04 ( 2H, CH2)

 

N2c.

IR (KBr) in cm-1 (Figure 5) :-  3512.2 (O-H stretching), 2920.6 (C-H stretching), 1696 (C=O stretching), 1574 (C=C stretching), 679.6 (C-I stretching),1265.8(N-H stretching).

1HNMR (300 MHz, CDCl3) δ in ppm (figure 6):-

δ 7.82 ( 1H, aromatic C-H), δ 8.26(1H, secondary N-H), δ 3.43 ( 2H, CH2)

Thus in the present work different N-(Substitute phenyl) anthranilic acids were synthesized and tested for a general profile of biological activity as anti-inflammatory. A series of N-(4-sulfonamidophenyl) anthranilic acids were synthesized by reaction of various substituted  anthranilic acid with O-chlorobenzoic acid  these were further substituted with iodine with the help of iodine monochloride.

 

The results showed that the N (substituted) phenyl anthranilic acid, N- (substituted sulfonamidophenyl) anthranilic acids, 5-iodo-N(substituted)phenylanthranilic acid,  i.e. all the derivatives tested showed a moderate spectrum of anti-inflammatory

 

Thus it is possible that substitution at position 2 of the anthranilic acid by sulfonamidophenyl and modification on the sulfonamide moiety by using various amines and substituting iodine on 5th position may yield compounds of much improved activity.

 

ACKNOWLEDGEMENT:

I wish to acknowledge Sophasticated Analytical nstumentation Facility Department of Centeral Drug Research Institute, Lucknow for providing facility of  I.R. and N.M.R. analysis of my samples.

 

REFERENCES:

1.       John H.Block, John M.Beale, “Wilson and Gisvold"s Text Book of medicinal and Pharmaceutical chemistry” ,11th edition, Lippincott Williams and   wilkin publication: pp 1-2.

2.       Thomas G., “Fundamentals of Medicinal Chemistry”, John Willey & Sons Ltd: pp 39-41, 77-78.

3.       Abraham D.J., “Burger’s Medicinal Chemistry & Drug Discovery” 6th  edition, John willey publication: pp 41-42.

4.       Goodman and Gilman's,‘The Pharmacological Basis of Therapeutics”,9th  edition,1996: pp 671.

5.       Jack Deruiter, Principal of Drug Action 2, Fall 2002.

6.       Woodfork KA, Dyke KV, “Anti-inflammatory and antirheumatic drugs”, 6th edn, Lippincott Williams and Wilkins  Philadelphia 2004:pp 423–439

7.       Kulkarni,R.G.,Achaiah,G.,NaehariG.,“Novel targets for anti inflammatory & Antiarthritic agents, current pharmaceutical Design,12(2006): pp 2437-2456.

8.       David A. W., Thomas L. Lemke,“Foye’s Principles of Medicinal Chemistry”, Lippincott Williams and Wilkins; 5th edition, pp 789-790.

9.       Tripathi K.D., “Essential of medical pharmacology” 5th edition,Jaypee Brothers and medical publishers, pp 168-171.

10.     Rang H.P., Dale M.M.,Ritter J.M. “Pharmacology”,5th edition, pp 244-45.

 

JOURNALS:

1.       Varnavas A., Valenta V., Berti F., Lassiani L., “Synthesis of N-terminal substituted anthranilic acid dimmer derivatives for evaluation on CCK receptors”, FARMACO year 2007, vol.56,  pp 555-564.

2.       Ratheesh M.,Helen A., “Antiinflammatory activity of Ruta Graveolens  Linn on carrageenan induced paw edema in wistar male rats.”  J.Biotech.,2007 vol.6(10): pp 1209-1211.

3.       Veerachamy A.,Viswas Raja S., Gnanavel V., Veeran P, Muniyandi R.C., “Synthesis, Analgesic, Anti-inflammatory and Antibacterial Activitie OF  Some Novel 2-Phenyl-3-substituted Quinazolin-4(3H) Ones”. Biol.  Pharm. Bull, 2002,vol 25(11): pp 1432-1435.

4.       Peter Werner feit et al synthesized new anthranilic acid derivatives being mono or di –N-substituted, having the ether or thio- ether group in the 4- position and an alkyl sulphonyl group and they reported diureticand saluretic activity with these derivatives.

 


 

 


 

 

Received on 20.03.2010        Modified on 18.04.2010

Accepted on 22.05.2010        © AJRC All right reserved

Asian J. Research Chem. 4(4): April 2011; Page 666-670